Literature DB >> 8739262

Plasticizer extraction of Taxol infusion solution from various infusion devices.

B Mass1, C Huber, I Krämer.   

Abstract

Taxol solution extracts the plasticizer DEHP (di(2-ethylhexyl)phthalate) from polyvinyl chloride (PVC) materials. In order to minimize patient exposure to DEHP, Taxol solutions should be prepared and administered in PVC-free materials. Particulate matter may form in Taxol infusion solution over time, so that in-line filtration with microporous membranes not greater than 0.22 microns is advisable. The purpose of this study was to evaluate the suitability of various administration- and in-line filter-sets for Taxol application. The extent of leached DEHP was determined using a Reversed Phase HPLC assay specific for DEHP. The four tested administration-sets, labeled as PVC-free, were all found to be suitable for Taxol application. The tested standard PVC-lined administration-set should not be used for Taxol application. Baxter Intermate LV 250 can be recommended as a disposable infusion device for ambulatory Taxol application. It can be connected with all the tested filter sets.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739262     DOI: 10.1007/bf00579710

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  24 in total

1.  Leachability of a new plasticizer tri-(2-ethylhexyl)-trimellitate from haemodialysis tubing.

Authors:  L M Flaminio; L De Angelis; M Ferazza; M Marinovich; G Galli; C L Galli
Journal:  Int J Artif Organs       Date:  1988-11       Impact factor: 1.595

2.  Letter: Particulate matter in polyvinyl chloride intravenous bags.

Authors:  T E Needham; L A Luzzi
Journal:  N Engl J Med       Date:  1973-12-06       Impact factor: 91.245

3.  Teratogenicity of phthalate esters in rats.

Authors:  A R Singh; W H Lawrence; J Autian
Journal:  J Pharm Sci       Date:  1972-01       Impact factor: 3.534

4.  Hepatic effects of the leaching of phthalate ester plasticizer and silicon.

Authors:  S Kevy; M Jacobson
Journal:  Contrib Nephrol       Date:  1983       Impact factor: 1.580

5.  Toxicology of a series of phthalate esters.

Authors:  D Calley; J Autian; W L Guess
Journal:  J Pharm Sci       Date:  1966-02       Impact factor: 3.534

Review 6.  Phthalate esters and their effect on the liver.

Authors:  A E Ganning; U Brunk; G Dallner
Journal:  Hepatology       Date:  1984 May-Jun       Impact factor: 17.425

7.  Hepatic studies of intraperitoneally administered tris(2-ethyl hexyl)trimellitate (TOTM) and di(2-ethyl hexyl)phthalate in rats.

Authors:  K Rathinam; S P Srivastava; P K Seth
Journal:  J Appl Toxicol       Date:  1990-02       Impact factor: 3.446

Review 8.  Pharmaceutical issues: preparation, administration, stability, and compatibility with other medications.

Authors:  B R Goldspiel
Journal:  Ann Pharmacother       Date:  1994-05       Impact factor: 3.154

Review 9.  Toxicology of di-2-ethylhexyl phthalate and other phthalic acid ester plasticizers.

Authors:  R M Gesler
Journal:  Environ Health Perspect       Date:  1973-01       Impact factor: 9.031

10.  Hepatic effects of a phthalate ester plasticizer leached from poly(vinyl chloride) blood bags following transfusion.

Authors:  S V Kevy; M S Jacobson
Journal:  Environ Health Perspect       Date:  1982-11       Impact factor: 9.031

View more
  3 in total

1.  Physico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containers.

Authors:  J Thiesen; I Krämer
Journal:  Pharm World Sci       Date:  1999-06

2.  Compatibility and stability of the investigational polypeptide marine anticancer agent kahalalide F in infusion devices.

Authors:  B Nuijen; M Bouma; C Manada; J M Jimeno; L L Lazaro; A Bult; J H Beijnen
Journal:  Invest New Drugs       Date:  2001       Impact factor: 3.850

Review 3.  Strategies to prevent drug incompatibility during simultaneous multi-drug infusion in intensive care units: a literature review.

Authors:  Laura Négrier; Anthony Martin Mena; Gilles Lebuffe; Pascal Odou; Stéphanie Genay; Bertrand Décaudin
Journal:  Eur J Clin Pharmacol       Date:  2021-03-25       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.